{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:40:23Z","timestamp":1793324423559,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02206-6","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T17:25:06Z","timestamp":1767547506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel insights into meningioma brain invasion with spatial transcriptomic profiling"],"prefix":"10.1186","volume":"14","author":[{"given":"Andrea Daniela","family":"Maier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes Ottzen","family":"Laurentiussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Regner","family":"Michaelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Perino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias Overlund","family":"Stannius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan Scott Lykke","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Nih\u00f8j","family":"Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Haslund-Vinding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai Schou","family":"Bager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scheie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane Yde","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linea Cecilie","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Au\u0161rin\u0117","family":"Are\u0161kevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Vilhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knud Elnegaard","family":"Josefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Otzen","family":"Bagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne Winther","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"2206_CR1","doi-asserted-by":"publisher","first-page":"III1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumor diagnosed in the united States in 2014\u20132018. Neuro Oncol 23:III1\u2013III105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro Oncol"},{"key":"2206_CR2","doi-asserted-by":"publisher","unstructured":"Perry A (2021) The definition and role of brain invasion in meningioma grading: still controversial after all these years. Free Neuropathol 2 0 SE-Opinion Piece). https:\/\/doi.org\/10.17879\/freeneuropathology-2021-3276","DOI":"10.17879\/freeneuropathology-2021-3276"},{"key":"2206_CR3","unstructured":"WHO Classification of Tumours Editorial Board (2021) World Health Organization Classification of Tumours of the Central Nervous System. 5th ed"},{"key":"2206_CR4","unstructured":"Louis D, Ohgaki H, Wiestler O, Cavenee W (2016) WHO Classification of Tumours of the Central Nervous System. 4th editio. International Agency for Research on Cancer, World Health Organization"},{"issue":"10","key":"2206_CR5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/neuonc\/nox071","volume":"19","author":"B Brokinkel","year":"2017","unstructured":"Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: A systematic review. Neuro Oncol 19(10):1298\u20131307. https:\/\/doi.org\/10.1093\/neuonc\/nox071","journal-title":"Neuro Oncol"},{"issue":"6","key":"2206_CR6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/nan.12700","volume":"47","author":"R Banan","year":"2021","unstructured":"Banan R, Abbetmeier-Basse M, Hong B et al (2021) The prognostic significance of clinicopathological features in meningiomas: microscopic brain invasion can predict patient outcome in otherwise benign meningiomas. Neuropathol Appl Neurobiol 47(6):724\u2013735. https:\/\/doi.org\/10.1111\/nan.12700","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"2206_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-016-1598-1","volume":"132","author":"P Baumgarten","year":"2016","unstructured":"Baumgarten P, Gessler F, Schittenhelm J et al (2016) Brain invasion in otherwise benign meningiomas does not predict tumor recurrence. Acta Neuropathol 132(3):479\u2013481. https:\/\/doi.org\/10.1007\/s00401-016-1598-1","journal-title":"Acta Neuropathol"},{"issue":"11","key":"2206_CR8","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23(11):1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"issue":"1","key":"2206_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122(1):4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"J Neurosurg"},{"issue":"2","key":"2206_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bpa.13048","volume":"32","author":"N von Spreckelsen","year":"2022","unstructured":"von Spreckelsen N, Kesseler C, Brokinkel B, Goldbrunner R, Perry A, Mawrin C (2022) Molecular neuropathology of brain-invasive meningiomas. Brain Pathol 32(2):1\u201310. https:\/\/doi.org\/10.1111\/bpa.13048","journal-title":"Brain Pathol"},{"issue":"3","key":"2206_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s10014-021-00399-x","volume":"38","author":"C Qin","year":"2021","unstructured":"Qin C, Huang M, Pan Y, Li Y, Long W, Liu Q (2021) Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options. Brain Tumor Pathol 38(3):156\u2013172. https:\/\/doi.org\/10.1007\/s10014-021-00399-x","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"2206_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-016-2297-4","volume":"131","author":"S Ricci","year":"2017","unstructured":"Ricci S, Guadagno E, Bruzzese D et al (2017) Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system. J Neurooncol 131(2):223\u2013232. https:\/\/doi.org\/10.1007\/s11060-016-2297-4","journal-title":"J Neurooncol"},{"key":"2206_CR13","doi-asserted-by":"publisher","unstructured":"Bouamrani A, Ramus C, Gay E et al (2010) Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas. Hofmann A, ed. PLoS One. ;5(2):e9238. https:\/\/doi.org\/10.1371\/journal.pone.0009238","DOI":"10.1371\/journal.pone.0009238"},{"issue":"2","key":"2206_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.26355\/eurrev_201801_14173","volume":"22","author":"J Pei","year":"2018","unstructured":"Pei J, Li P, Zhang Z-Y et al (2018) Effect of TAGLN2 in the regulation of meningioma tumorigenesis and development. Eur Rev Med Pharmacol Sci 22(2):307\u2013313. https:\/\/doi.org\/10.26355\/eurrev_201801_14173","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2206_CR15","doi-asserted-by":"crossref","unstructured":"Borch JDS, Haslund-vinding J, Vilhardt F, Maier AD, Mathiesen T Meningioma \u2013 Brain Crosstalk: Scoping Rev Published Online 2021:1\u201314","DOI":"10.1016\/j.bas.2021.100533"},{"issue":"1","key":"2206_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13073-022-01051-9","volume":"14","author":"AZ Wang","year":"2022","unstructured":"Wang AZ, Bowman-Kirigin JA, Desai R et al (2022) Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response. Genome Med 14(1):49. https:\/\/doi.org\/10.1186\/s13073-022-01051-9","journal-title":"Genome Med"},{"issue":"12","key":"2206_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/jnen\/nlad093","volume":"82","author":"N Blum","year":"2023","unstructured":"Blum N, Mirian C, Maier AD, Mathiesen TI, Vilhardt F, Haslund-Vinding JL (2023) Translocator protein (TSPO) expression in neoplastic cells and tumor-associated macrophages in meningiomas. J Neuropathol Exp Neurol 82(12):1020\u20131032. https:\/\/doi.org\/10.1093\/jnen\/nlad093","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2206_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/noajnl\/vdz018","volume":"1","author":"DT Proctor","year":"2019","unstructured":"Proctor DT, Huang J, Lama S, Albakr A, Van Marle G, Sutherland GR (2019) Tumor-associated macrophage infiltration in meningioma. Neuro-Oncology Adv 1(1):1\u201310. https:\/\/doi.org\/10.1093\/noajnl\/vdz018","journal-title":"Neuro-Oncology Adv"},{"issue":"3","key":"2206_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/neuonc\/noac224","volume":"25","author":"A Choudhury","year":"2023","unstructured":"Choudhury A, Chen WC, Lucas C-HG et al (2023) Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro Oncol 25(3):520\u2013530. https:\/\/doi.org\/10.1093\/neuonc\/noac224","journal-title":"Neuro Oncol"},{"key":"2206_CR20","doi-asserted-by":"publisher","unstructured":"Nassiri F, Liu J, Patil V et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597(September). https:\/\/doi.org\/10.1038\/s41586-021-03850-3","DOI":"10.1038\/s41586-021-03850-3"},{"issue":"1","key":"2206_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2990.2008.00960.x","volume":"35","author":"S Grund","year":"2009","unstructured":"Grund S, Schittenhelm J, Roser F et al (2009) The microglial\/macrophagic response at the tumour-brain border of invasive meningiomas. Neuropathol Appl Neurobiol 35(1):82\u201388. https:\/\/doi.org\/10.1111\/j.1365-2990.2008.00960.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"11","key":"2206_CR22","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/neuonc\/noab075","volume":"23","author":"J Yeung","year":"2021","unstructured":"Yeung J, Yaghoobi V, Miyagishima D et al (2021) Targeting the CSF1\/CSF1R axis is a potential treatment strategy for malignant meningiomas. Neuro Oncol 23(11):1922\u20131935. https:\/\/doi.org\/10.1093\/neuonc\/noab075","journal-title":"Neuro Oncol"},{"key":"2206_CR23","doi-asserted-by":"publisher","unstructured":"Maddy Griswold, Ortogero N, Yang Z, Vitanco R, Henderson D GeomxTools: Tools for NanoString Technologies GeoMx Technology. Published online 2024. https:\/\/doi.org\/10.18129\/B9.bioc.GeomxTools","DOI":"10.18129\/B9.bioc.GeomxTools"},{"key":"2206_CR24","doi-asserted-by":"publisher","DOI":"10.18129\/B9.bioc.preprocessCore","author":"B Bolstad","year":"2023","unstructured":"Bolstad B, preprocessCore: (2023) A collection of pre-processing functions. Published Online. https:\/\/doi.org\/10.18129\/B9.bioc.preprocessCore","journal-title":"Published Online"},{"issue":"1","key":"2206_CR25","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.isci.2022.105760","volume":"26","author":"L van Hijfte","year":"2023","unstructured":"van Hijfte L, Geurts M, Vallentgoed WR et al (2023) Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx digital Spatial profiling data. iScience 26(1):105760. https:\/\/doi.org\/10.1016\/j.isci.2022.105760","journal-title":"iScience"},{"key":"2206_CR26","doi-asserted-by":"publisher","unstructured":"Choudhury A, Magill ST, Eaton CD et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(MaY). https:\/\/doi.org\/10.1038\/s41588-022-01061-8","DOI":"10.1038\/s41588-022-01061-8"},{"issue":"7","key":"2206_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47\u2013e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"2206_CR28","doi-asserted-by":"publisher","unstructured":"Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK (2016) Robust hyperparameter Estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat 10(2). https:\/\/doi.org\/10.1214\/16-AOAS920","DOI":"10.1214\/16-AOAS920"},{"issue":"1","key":"2206_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J R Stat Soc Ser B"},{"key":"2206_CR30","doi-asserted-by":"publisher","unstructured":"Zhang J, Hu S, Li Y (2019) KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer. Biosci Rep 39(8). https:\/\/doi.org\/10.1042\/BSR20190884","DOI":"10.1042\/BSR20190884"},{"issue":"1","key":"2206_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1440-1681.13401","volume":"48","author":"P Wang","year":"2021","unstructured":"Wang P, Chen Y, Ding G, Du H, Fan H (2021) Keratin 18 induces proliferation, migration, and invasion in gastric cancer via the MAPK signalling pathway. Clin Exp Pharmacol Physiol 48(1):147\u2013156. https:\/\/doi.org\/10.1111\/1440-1681.13401","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"2206_CR32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/hupa.2002.124912","volume":"33","author":"M Miettinen","year":"2002","unstructured":"Miettinen M, Paetau A (2002) Mapping of the keratin polypeptides in meningiomas of different types: an immunohistochemical analysis of 463 cases. Hum Pathol 33(6):590\u2013598. https:\/\/doi.org\/10.1053\/hupa.2002.124912","journal-title":"Hum Pathol"},{"issue":"1","key":"2206_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00280-015-2927-0","volume":"77","author":"E Mazza","year":"2016","unstructured":"Mazza E, Brandes A, Zanon S et al (2016) Hydroxyurea with or without Imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by gruppo Italiano cooperativo Di Neuro-Oncologia (GICNO). Cancer Chemother Pharmacol 77(1):115\u2013120. https:\/\/doi.org\/10.1007\/s00280-015-2927-0","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"2206_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E, THE METABOLISM OF TUMORS (1927) IN THE BODY. J Gen Physiol 8(6):519\u2013530. https:\/\/doi.org\/10.1085\/jgp.8.6.519","journal-title":"J Gen Physiol"},{"key":"2206_CR35","doi-asserted-by":"publisher","first-page":"149155","DOI":"10.1016\/j.gene.2024.149155","volume":"937","author":"S Xue","year":"2025","unstructured":"Xue S, Luo Z, Mao Y, Liu S (2025) A comprehensive analysis of the pyruvate kinase M1\/2 (PKM) in human cancer. Gene 937:149155. https:\/\/doi.org\/10.1016\/j.gene.2024.149155","journal-title":"Gene"},{"issue":"3","key":"2206_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11060-023-04521-1","volume":"165","author":"BB Yavuz","year":"2023","unstructured":"Yavuz BB, Kilinc F, Kanyilmaz G, Aktan M (2023) Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients. J Neurooncol 165(3):527\u2013533. https:\/\/doi.org\/10.1007\/s11060-023-04521-1","journal-title":"J Neurooncol"},{"issue":"12","key":"2206_CR37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/1758834017742576","volume":"9","author":"Z Yang","year":"2017","unstructured":"Yang Z, Jiang S, Cheng Y et al (2017) FOXC1 in cancer development and therapy: Deciphering its emerging and divergent roles. Ther Adv Med Oncol 9(12):797\u2013816. https:\/\/doi.org\/10.1177\/1758834017742576","journal-title":"Ther Adv Med Oncol"},{"key":"2206_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2022.7.JNS22585","volume":"1","author":"AD Maier","year":"2022","unstructured":"Maier AD, Meddis A, Mirian C et al (2022) Gene expression analysis during progression of malignant meningioma compared to benign meningioma. J Neurosurg Published Online September 1:1\u201311. https:\/\/doi.org\/10.3171\/2022.7.JNS22585","journal-title":"J Neurosurg Published Online September"},{"issue":"1","key":"2206_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.devcel.2020.06.009","volume":"54","author":"J DeSisto","year":"2020","unstructured":"DeSisto J, O\u2019Rourke R, Jones HE et al (2020) Single-Cell transcriptomic analyses of the developing meninges reveal meningeal fibroblast diversity and function. Dev Cell 54(1):43\u201359e4. https:\/\/doi.org\/10.1016\/j.devcel.2020.06.009","journal-title":"Dev Cell"},{"issue":"12","key":"2206_CR40","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1128\/MCB.00281-14","volume":"34","author":"AC Vreeland","year":"2014","unstructured":"Vreeland AC, Yu S, Levi L, de Barros Rossetto D, Noy N (2014) Transcript stabilization by the RNA-Binding protein HuR is regulated by cellular retinoic Acid-Binding protein 2. Mol Cell Biol 34(12):2135\u20132146. https:\/\/doi.org\/10.1128\/MCB.00281-14","journal-title":"Mol Cell Biol"},{"key":"2206_CR41","doi-asserted-by":"publisher","unstructured":"Senglek K, Teerapakpinyo C, Jittapiromsak N et al (2024) Differential expression of proteins and genes at the Tumor-Brain interface in invasive meningioma. Genes Chromosom Cancer 63(11). https:\/\/doi.org\/10.1002\/gcc.70007","DOI":"10.1002\/gcc.70007"},{"issue":"6","key":"2206_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41588-024-01747-1","volume":"56","author":"C-HG Lucas","year":"2024","unstructured":"Lucas C-HG, Mirchia K, Seo K et al (2024) Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution. Nat Genet 56(6):1121\u20131133. https:\/\/doi.org\/10.1038\/s41588-024-01747-1","journal-title":"Nat Genet"},{"issue":"15","key":"2206_CR43","first-page":"3226","volume":"58","author":"EP Sulman","year":"1998","unstructured":"Sulman EP, Dumanski JP, White PS et al (1998) Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res 58(15):3226\u20133230. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9699646","journal-title":"Cancer Res"},{"issue":"7","key":"2206_CR44","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1158\/0008-5472.CAN-04-3651","volume":"65","author":"PG Buckley","year":"2005","unstructured":"Buckley PG, Jarbo C, Menzel U et al (2005) Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. Cancer Res 65(7):2653\u20132661. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3651","journal-title":"Cancer Res"},{"issue":"1","key":"2206_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-025-01973-6","volume":"13","author":"G Zanconato","year":"2025","unstructured":"Zanconato G, Hernandez Gamero G, Mafficini A et al (2025) Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion. Acta Neuropathol Commun 13(1):50. https:\/\/doi.org\/10.1186\/s40478-025-01973-6","journal-title":"Acta Neuropathol Commun"},{"issue":"14","key":"2206_CR46","doi-asserted-by":"publisher","first-page":"12094","DOI":"10.18632\/oncotarget.3297","volume":"6","author":"M Aubry","year":"2015","unstructured":"Aubry M, de Tayrac M, Etcheverry A et al (2015) From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget 6(14):12094\u201312109. https:\/\/doi.org\/10.18632\/oncotarget.3297","journal-title":"Oncotarget"},{"key":"2206_CR47","doi-asserted-by":"publisher","unstructured":"Ralph S, Mani S, Swargiary G et al (2023) Therapeutic targeting of mitochondrial plasticity and redox control to overcome cancer Chemoresistance. Antioxid redox signal. Published Online July 20. https:\/\/doi.org\/10.1089\/ars.2023.0379","DOI":"10.1089\/ars.2023.0379"},{"issue":"1","key":"2206_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"S-F Wang","year":"2023","unstructured":"Wang S-F, Tseng L-M, Lee H-C (2023) Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci 30(1):61. https:\/\/doi.org\/10.1186\/s12929-023-00956-w","journal-title":"J Biomed Sci"},{"issue":"1","key":"2206_CR49","doi-asserted-by":"publisher","first-page":"114316","DOI":"10.1016\/j.yexcr.2024.114316","volume":"443","author":"F Wang","year":"2024","unstructured":"Wang F, Jiang C, Hui H-X et al (2024) cGAS regulates metabolic reprogramming independently of STING pathway in colorectal cancer. Exp Cell Res 443(1):114316. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114316","journal-title":"Exp Cell Res"},{"key":"2206_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07357907.2024.2430283","volume":"25","author":"X Hu","year":"2024","unstructured":"Hu X, Huang Z, Li L (2024) LDHB mediates histone lactylation to activate PD-L1 and promote ovarian cancer immune escape. Cancer Invest Published Online November 25:1\u201310. https:\/\/doi.org\/10.1080\/07357907.2024.2430283","journal-title":"Cancer Invest Published Online November"},{"issue":"3","key":"2206_CR51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.drudis.2021.12.008","volume":"27","author":"Y Larasati","year":"2022","unstructured":"Larasati Y, Boudou C, Koval A, Katanaev VL (2022) Unlocking the Wnt pathway: therapeutic potential of selective targeting FZD7 in cancer. Drug Discov Today 27(3):777\u2013792. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.008","journal-title":"Drug Discov Today"},{"issue":"3","key":"2206_CR52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.23756","volume":"14","author":"G Li","year":"2018","unstructured":"Li G, Su Q, Liu H et al (2018) Frizzled7 promotes Epithelial-to-mesenchymal transition and stemness via activating canonical Wnt\/\u03b2-catenin pathway in gastric cancer. Int J Biol Sci 14(3):280\u2013293. https:\/\/doi.org\/10.7150\/ijbs.23756","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2206_CR53","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12094-023-03242-1","volume":"26","author":"E Khodaverdi","year":"2023","unstructured":"Khodaverdi E, Shabani AA, Madanchi H, Farahmand L (2023) Synthesis of the ScFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study. Clin Transl Oncol 26(1):231\u2013238. https:\/\/doi.org\/10.1007\/s12094-023-03242-1","journal-title":"Clin Transl Oncol"},{"key":"2206_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18582-7","author":"ST Magill","year":"2020","unstructured":"Magill ST, Vasudevan HN, Seo K et al (2020) Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nat Commun Published Online. https:\/\/doi.org\/10.1038\/s41467-020-18582-7","journal-title":"Nat Commun Published Online"},{"key":"2206_CR55","doi-asserted-by":"publisher","unstructured":"Eaton C, Avalos L, Liu SJ et al (2023) MerlinS13 phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. Res Sq Published Online March 14. https:\/\/doi.org\/10.21203\/rs.3.rs-2577844\/v1","DOI":"10.21203\/rs.3.rs-2577844\/v1"},{"issue":"1","key":"2206_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Mol Brain Res 57(1):1\u20139. https:\/\/doi.org\/10.1016\/S0169-328X(98)00040-0","journal-title":"Mol Brain Res"},{"key":"2206_CR57","doi-asserted-by":"publisher","unstructured":"Easley-Neal C, Foreman O, Sharma N, Zarrin AA, Weimer RM (2019) CSF1R ligands IL-34 and CSF1 are differentially required for microglia development and maintenance in white and Gray matter brain regions. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02199","DOI":"10.3389\/fimmu.2019.02199"},{"issue":"2","key":"2206_CR58","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MRP Elmore","year":"2014","unstructured":"Elmore MRP, Najafi AR, Koike MA et al (2014) Colony-Stimulating factor 1 receptor signaling is necessary for microglia Viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82(2):380\u2013397. https:\/\/doi.org\/10.1016\/j.neuron.2014.02.040","journal-title":"Neuron"},{"key":"2206_CR59","doi-asserted-by":"publisher","unstructured":"Stanley ER, Biundo F, G\u00f6khan \u015e, Chitu V (2023) Differential regulation of microglial States by colony stimulating factors. Front Cell Neurosci 17. https:\/\/doi.org\/10.3389\/fncel.2023.1275935","DOI":"10.3389\/fncel.2023.1275935"},{"issue":"38","key":"2206_CR60","doi-asserted-by":"publisher","first-page":"23336","DOI":"10.1073\/pnas.1922788117","volume":"117","author":"F Lei","year":"2020","unstructured":"Lei F, Cui N, Zhou C, Chodosh J, Vavvas DG, Paschalis EI (2020) CSF1R Inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc Natl Acad Sci U S A 117(38):23336\u201323338. https:\/\/doi.org\/10.1073\/pnas.1922788117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2206_CR61","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1242\/jcs.104.4.1021","volume":"104","author":"MD Witmer-Pack","year":"1993","unstructured":"Witmer-Pack MD, Hughes DA, Schuler G et al (1993) Identification of macrophages and dendritic cells in the osteopetrotic (op\/op) mouse. J Cell Sci 104(4):1021\u20131029. https:\/\/doi.org\/10.1242\/jcs.104.4.1021","journal-title":"J Cell Sci"},{"issue":"15","key":"2206_CR62","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1073\/pnas.87.15.5613","volume":"87","author":"JH Pierce","year":"1990","unstructured":"Pierce JH, Di Marco E, Cox GW et al (1990) Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms\/CSF-1 receptor cDNA. Proc Natl Acad Sci 87(15):5613\u20135617. https:\/\/doi.org\/10.1073\/pnas.87.15.5613","journal-title":"Proc Natl Acad Sci"},{"key":"2206_CR63","doi-asserted-by":"publisher","first-page":"114884","DOI":"10.1016\/j.ejmech.2022.114884","volume":"245","author":"J Wen","year":"2023","unstructured":"Wen J, Wang S, Guo R, Liu D (2023) CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment. Eur J Med Chem 245:114884. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114884","journal-title":"Eur J Med Chem"},{"key":"2206_CR64","doi-asserted-by":"publisher","first-page":"104729","DOI":"10.1016\/j.cellimm.2023.104729","volume":"390","author":"AK Moustakas","year":"2023","unstructured":"Moustakas AK, Nguyen H, James EA, Papadopoulos GK (2023) Autoimmune susceptible HLA class II motifs facilitate the presentation of modified neoepitopes to potentially autoreactive T cells. Cell Immunol 390:104729. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104729","journal-title":"Cell Immunol"},{"key":"2206_CR65","doi-asserted-by":"publisher","unstructured":"Shi K, Li Q-Y, Zhang Y-Q et al (2023) HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma. Aging (Albany NY) Published Online Oct 27. https:\/\/doi.org\/10.18632\/aging.205082","DOI":"10.18632\/aging.205082"},{"key":"2206_CR66","doi-asserted-by":"publisher","first-page":"113706","DOI":"10.1016\/j.intimp.2024.113706","volume":"144","author":"F Xiong","year":"2025","unstructured":"Xiong F, Wang B, Zhang H et al (2025) Human leukocyte antigen DR alpha inhibits renal cell carcinoma progression by promoting the polarization of M2 macrophages to M1 via the NF-\u03baB pathway. Int Immunopharmacol 144:113706. https:\/\/doi.org\/10.1016\/j.intimp.2024.113706","journal-title":"Int Immunopharmacol"},{"key":"2206_CR67","doi-asserted-by":"publisher","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. January31\u201347. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","DOI":"10.1158\/2159-8290.CD-21-1059"},{"issue":"2","key":"2206_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-023-02605-w","volume":"146","author":"G Medici","year":"2023","unstructured":"Medici G, Freudenmann LK, Velz J et al (2023) A T-cell antigen atlas for meningioma: novel options for immunotherapy. Acta Neuropathol 146(2):173\u2013190. https:\/\/doi.org\/10.1007\/s00401-023-02605-w","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2206_CR69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1742-2094-8-130","volume":"8","author":"KR Byrnes","year":"2011","unstructured":"Byrnes KR, Washington PM, Knoblach SM, Hoffman E, Faden AI (2011) Delayed inflammatory mRNA and protein expression after spinal cord injury. J Neuroinflammation 8(1):130. https:\/\/doi.org\/10.1186\/1742-2094-8-130","journal-title":"J Neuroinflammation"},{"key":"2206_CR70","doi-asserted-by":"publisher","unstructured":"Grauers Wiktorin H, Aydin E, Hellstrand K, Martner A (2020) NOX2-Derived Reactive Oxygen Species in Cancer. Ghose J, ed. Oxid Med Cell Longev. ;2020:1\u201315. https:\/\/doi.org\/10.1155\/2020\/7095902","DOI":"10.1155\/2020\/7095902"},{"issue":"2","key":"2206_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/neuonc\/3.2.73","volume":"3","author":"T Iida","year":"2001","unstructured":"Iida T, Furuta A, Kawashima M, Nishida J, Nakabeppu Y, Iwaki T (2001) Accumulation of 8-oxo-2\u2032-deoxyguanosine and increased expression of hMTH1 protein in brain tumors. Neuro Oncol 3(2):73\u201381. https:\/\/doi.org\/10.1093\/neuonc\/3.2.73","journal-title":"Neuro Oncol"},{"issue":"12","key":"2206_CR72","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1111\/bph.13426","volume":"174","author":"F Vilhardt","year":"2017","unstructured":"Vilhardt F, Haslund-Vinding J, Jaquet V, McBean G (2017) Microglia antioxidant systems and redox signalling. Br J Pharmacol 174(12):1719\u20131732. https:\/\/doi.org\/10.1111\/bph.13426","journal-title":"Br J Pharmacol"},{"key":"2206_CR73","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbi.2016.07.158","volume":"58","author":"A Kumar","year":"2016","unstructured":"Kumar A, Barrett JP, Alvarez-Croda D-M, Stoica BA, Faden AI, Loane DJ (2016) NOX2 drives M1-like microglial\/macrophage activation and neurodegeneration following experimental traumatic brain injury. Brain Behav Immun 58:291\u2013309. https:\/\/doi.org\/10.1016\/j.bbi.2016.07.158","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2206_CR74","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1089\/ars.2010.3635","volume":"15","author":"O Sareila","year":"2011","unstructured":"Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R (2011) NOX2 Complex\u2013Derived ROS as immune regulators. Antioxid Redox Signal 15(8):2197\u20132208. https:\/\/doi.org\/10.1089\/ars.2010.3635","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"2206_CR75","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","volume":"27","author":"F Sahm","year":"2025","unstructured":"Sahm F, Aldape KD, Brastianos PK et al (2025) cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro Oncol 27(2):319\u2013330. https:\/\/doi.org\/10.1093\/neuonc\/noae170","journal-title":"Neuro Oncol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02206-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:01:57Z","timestamp":1770120117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02206-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2206"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02206-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The Regional Research Ethics Committees, Capital Region of Denmark (approval number H-6-2014-010 with addendum no. 86217) and the need for patient consent was waived. The data handling was approved by the Danish Data Protection Agency (approval number VD-2018-365).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}